ObjectiveThe objective of this study was to assess the correlation between antenatal corticosteroids and peri-intraventricular haemorrhage (PIVH) using transfontanelle ultrasonography, as well as to evaluate the risk factors for its incidence.MethodsWe performed a retrospective cohort study using medical records of preterm newborns. The protocol for maternal corticoid administration for foetal lung maturation included dexamethasone 4 mg (intramuscular) 8/8 hours per 48 hours, with one cycle per week. The diagnosis of periintraventricular haemorrhage was based on transfontanelle ultrasonography, using the Papile’s classification. The following risk factors for peri-intraventricular haemorrhage were assessed: birth weight, gestational age at delivery, type of delivery, newborn’s sex, surfactant administration, premature rupture of membranes and previous history of infection during the current pregnancy. The student’s t-test and chi-square test were used for statistical analysis.ResultsOur sample population included 184 preterm newborns. Transfontanelle ultrasonography revealed peri-intraventricular haemorrhage in 32 (74.4%) and periventricular leukomalacia in 11 (25.6%) newborns. Grade I haemorrhage was found in 20 (62.5%), grade II in five (15.6%), and grade III in seven (21.8%) newborns, as in accordance with Papile’s classification. Vaginal delivery (p = 0.010), birth weight <1500 g (p = 0.024), gestational age at delivery ≤32 weeks (p = 0.018), and previous history of infection during pregnancy (p = 0.013) were considered risk factors for peri-intraventricular haemorrhage in preterm newborns.ConclusionMaternal corticoid administration for foetal lung maturation showed a protective effect against peri-intraventricular haemorrhage in preterm newborns. The risk factors for peri-intraventricular haemorrhage were determined.
Background. Congenital toxoplasmosis (CT) is an infectious disease caused by placental transfer of Toxoplasma gondii protozoa to the fetus, and can generate neurological and neurocognitive deficits, or death. As a mother’s infection poses the risk of fetal transmission in about 30% of the cases, appropriate preventive strategies are required for infection-related risk factors. The present study assessed the prevalence of T. gondii infection and the factors associated with congenital toxoplasmosis in pregnant women with assistance from the Public Health Service at Ouro Preto, Brazil.Methods. This cross-sectional study was conducted between April and December 2020. Pregnant women (n = 131) aged between 13 and 46 years, were recruited and evaluated for specific IgM and IgG antibody levels against T. gondii. These women also responded to a structured questionnaire, which was later used to determine the socioeconomic, environmental, gestational, clinical, and dietary patterns.Results. The prevalence of infection by T. gondii was 45.8% (n = 60); of these, multigravida women were more exposed to infection and were 2.6 times more likely to become infected with T. gondii compared to primigravida women (OR: 2.60; 95% CI: 1.25-5.39). A high prevalence of T. gondii seropositivity was identified in pregnant women in the region of Ouro Preto, Brazil, where part of the sample reported the absence of basic sanitation at home.Conclusion. Our data identified multigravida as a potential risk factor for gestational toxoplasmosis, based on the high positivity of anti-T. gondii serology in these women Thus, educational and preventive measures must be intensified in both primigravida and multigravida women, to increase awareness regarding the potential risks of contact with T. gondii.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.